Search research articles
Contact Us
Filters
Showing results (71-80 of 103) with videos related to
Page
of 11
Sort By:
The Journal of Pathology
|
May 11, 2013
Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing
Ian J Majewski, Lorenza Mittempergher, Nadia M Davidson, et al.
Cancers
|
December 11, 2022
Homologous Recombination Deficiency and Cyclin E1 Amplification Are Correlated with Immune Cell Infiltration and Survival in High-Grade Serous Ovarian Cancer
Lilian van Wagensveld, Juliette O A M van Baal, Maite Timmermans, et al.
Iscience
|
August 29, 2024
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial
Mark Opdam, Annelot G J van Rossum, Marlous Hoogstraat, et al.
Genome Medicine
|
October 27, 2015
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Andrew E Teschendorff, Shih-Han Lee, Allison Jones, et al.
NPJ Breast Cancer
|
May 22, 2020
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
Jan Hudeček, Leonie Voorwerk, Maartje van Seijen, et al.
International Journal of Cancer
|
May 18, 2022
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial
Simone N Koole, Philip C Schouten, Jan Hauke, et al.
Nature Cancer
|
April 10, 2023
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial
Leonie Voorwerk, Olga I Isaeva, Hugo M Horlings, et al.
Cancer Discovery
|
February 9, 2026
Single-cell spatial atlas of high-grade serous ovarian cancer uncovers MHC class II as a key predictor of spatial tumor ecosystems and clinical outcomes
Fernando Perez-Villatoro, Aleksandra Shabanova, Lilian van Wagensveld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments
Lennart Kester, Danielle Seinstra, Annelot G J van Rossum, et al.
Nature Genetics
|
April 25, 2017
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
Yi Kan Wang, Ali Bashashati, Michael S Anglesio, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 103) with videos related to
Sort By:
Page
of 11
The Journal of Pathology
|
May 11, 2013
Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing
Ian J Majewski, Lorenza Mittempergher, Nadia M Davidson, et al.
Cancers
|
December 11, 2022
Homologous Recombination Deficiency and Cyclin E1 Amplification Are Correlated with Immune Cell Infiltration and Survival in High-Grade Serous Ovarian Cancer
Lilian van Wagensveld, Juliette O A M van Baal, Maite Timmermans, et al.
Iscience
|
August 29, 2024
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial
Mark Opdam, Annelot G J van Rossum, Marlous Hoogstraat, et al.
Genome Medicine
|
October 27, 2015
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Andrew E Teschendorff, Shih-Han Lee, Allison Jones, et al.
NPJ Breast Cancer
|
May 22, 2020
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
Jan Hudeček, Leonie Voorwerk, Maartje van Seijen, et al.
International Journal of Cancer
|
May 18, 2022
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial
Simone N Koole, Philip C Schouten, Jan Hauke, et al.
Nature Cancer
|
April 10, 2023
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial
Leonie Voorwerk, Olga I Isaeva, Hugo M Horlings, et al.
Cancer Discovery
|
February 9, 2026
Single-cell spatial atlas of high-grade serous ovarian cancer uncovers MHC class II as a key predictor of spatial tumor ecosystems and clinical outcomes
Fernando Perez-Villatoro, Aleksandra Shabanova, Lilian van Wagensveld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments
Lennart Kester, Danielle Seinstra, Annelot G J van Rossum, et al.
Nature Genetics
|
April 25, 2017
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
Yi Kan Wang, Ali Bashashati, Michael S Anglesio, et al.
Page
of 11